Close Menu

NEW YORK (GenomeWeb) – Meridian Bioscience today reported a 7 percent year-over-year uptick in fiscal first quarter revenues driven by balanced contributions from its key operating segments.

For the three months ended Dec. 31, the Cincinnati-based molecular diagnostics and life science research tools firm brought in revenue of $48 million compared to $44.8 million in the same quarter last year and beating the consensus analysts' estimate of $46.2 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Wall Street Journal reports on the struggle to meet the demand for rapid COVID-19 testing.

The Newsroom reports New Zealand is using genomics to trace the origins of its new coronavirus outbreak.

In Nature this week: researchers in Canada sequence the genome of the black mustard plant Brassica nigra, and more.

According to Bloomberg, Moderna has a $1.5 billion vaccine deal with the US to provide 100 million doses.